SINGAPORE--(Marketwired - Jun 27, 2014) -
Phorm Corporation Limited
("Phorm" or the "Company")
Notice of Annual General Meeting and Board Changes
Phorm (AIM: PHRM), a leading internet personalisation technology company, announces that its forthcoming Annual General Meeting ("AGM") will be held at 11.00 a.m. (London time) on Thursday 24 July 2014 at the offices of Hogan Lovells International LLP, Atlantic House, Holborn Viaduct, London EC1A 2FG.
The formal notice convening and outlining details of the AGM is being posted to shareholders today and, once posted, will also be made available to download from the Investor Relations section of the Company's website at www.phorm.com.
Board Changes
Phorm is also pleased to announce that Mr Johannes Minho Roth will be appointed as a Non-Executive Director of the Company on 24 July 2014, subject to shareholders' approval at the abovementioned AGM. Mr Roth is the founding director and partner at FiveT Capital Holding AG, a Switzerland-based innovative financial holdings firm. He has many years experience of international markets and technology businesses including acting as Chief Executive Officer at FiveT Capital AG and as an equity specialist and proprietary trader at Baaderbank AG. Mr Roth also holds a Masters degree (diploma) in Economics from Hohenheim University, in Germany.
In addition, the Company announces that Christophe Delorme will step down from the Board with effect from the conclusion of the abovementioned AGM to focus on his other business interests, including his role as CEO of NFT Investment PTE Ltd.
Kent Ertugrul, Chairman and CEO of Phorm commented:
"We are delighted to welcome Johannes to the Phorm Board. His valuable experience of international markets and technology businesses will assist with the group's future growth and development.
"We are grateful for the important contribution Christophe has made to Phorm and wish him well in his future endeavours.
"The composition of the Board is reviewed on a regular basis and it remains our intention to appoint an independent Chairman at the appropriate stage in the Company's commercial development."
Additional information on Mr Johannes Minho Roth
The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies:
Johannes Minho Roth (aged 35)
| Current Directorships/Partnerships | Past Directorships/Partnerships (last 5 years) | |
| FiveT Capital Holding AG | None | |
| FiveT Capital AG | ||
| Insilico Biotechnology AG | ||
| Plug Power, Inc. | ||
| Amorfix Life Sciences Ltd | ||
| Fanorakel AG |
As noted above, Mr Roth is the founding director and partner at FiveT Capital AG which is currently interested in 25,545,000 ordinary shares of nil par value each in the capital of Phorm, representing approximately 4.12 per cent. of the Company's existing issued share capital.
There is no other information that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies.
-Ends-